Skip to main content
Login
User menu
Mega menu
EASL Home
Resources
EASL Resources
All Resources
Basic Techniques in Experimental Hepatology at a Glance
Clinical Practice Guidelines
Congress Resources
COVID-19 Resources
EASL Quiz
ePosters
Journal Club
Nurses and AHPs
On-demand Webinars
Webinars
Online Courses
Podcasts
Slide Decks
Webcasts
Other Resources
ERN Rare-Liver On-demand Webinars
Baveno VII - Consensus Workshop
Baveno VII - Pediatric Research Workshop
Industry Resources
All Resources
Industry Symposia - International Liver Congress
Industry Symposia - NAFLD Summit 2022
Industry Symposia - Liver Cancer Summit
Online Course - NASH: From pathogenesis to non-invasive testing
Patient Resources
All Resources
ePosters
COVID-19 Resources
Infographics
Patient Guidelines
PDF
Podcasts
Slide Decks
Takeaways
Webcasts
EASL Studio
EASL Campus Connect
My Community
Explore Community
EASL Community Feed
All Topics
Community FAQ's
Create
Our Sponsors
A 24-year-old woman presents at week 20 of her pregnancy. She is referred because she has chronic hepatitis B with a viral load of 400,000 IU/ml HBV-DNA.
Which measures beyond simultaneous active-passive immunization of the newborn immediately after delivery would you recommend to this patient in order to prevent vertical mother-baby transmission?
A. Breastfeeding
B. Delivery via caesarian section
C. Treatment with tenofovir from week 24 of pregnancy
D. None of the above
Submit
Explore Community
Community Stream
Easl Community Feed
My Feed
Browse Stream
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Privacy Policy
Cookie Policy